We can't find the internet
Attempting to reconnect
25174.1 PFLS-LS
Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification
Zusammenfassung
Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification
Weitere Texte
Abstract
Inositec#s proprietary platform of small molecules have been derived from a natural compound and engineered for therapeutic potential. The present project aims to establish pre-clinical proof-of-concept for a novel inhibitor of vascular calcification for chronic kidney disease patients. Vascular calcification is a common consequence of renal insufficiency leading to cardiovascular disease for which there are currently no approved treatments.
Beteiligte
Matthias Ivarsson
Wirtschaftspartner
mattias@inositec.com
Inositec AG Matthias Ivarsson Technoparkstrasse 1 8005 Zürich ZH CH
Jean-Christophe Leroux
Kontaktperson
jean-christophe.leroux@pharma.ethz.ch
ETH Zürich Jean-Christophe Leroux Vladimir-Prelog-Weg 1-5/10 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-12-31
- Enddatum
- 2018-11-30
- Bewilligte Gesamtkosten
- CHF 244419.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%